Medtronic PLC (MDT): Price and Financial Metrics
GET POWR RATINGS... FREE!
MDT POWR Grades
- MDT scores best on the Value dimension, with a Value rank ahead of 82.4% of US stocks.
- MDT's strongest trending metric is Stability; it's been moving down over the last 177 days.
- MDT's current lowest rank is in the Momentum metric (where it is better than 43.36% of US stocks).
MDT Stock Summary
- MDT has a market capitalization of $113,384,541,325 -- more than approximately 98.06% of US stocks.
- With a one year PEG ratio of 280.98, MEDTRONIC PLC is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 90.55% of US stocks.
- MEDTRONIC PLC's stock had its IPO on January 1, 1986, making it an older stock than 93.46% of US equities in our set.
- Stocks that are quantitatively similar to MDT, based on their financial statements, market capitalization, and price volatility, are SYK, CAT, IBM, GE, and ZTS.
- Visit MDT's SEC page to see the company's official filings. To visit the company's web site, go to www.medtronic.com.
MDT Valuation Summary
- In comparison to the median Healthcare stock, MDT's EV/EBIT ratio is 109.85% higher, now standing at 21.3.
- Over the past 243 months, MDT's EV/EBIT ratio has gone down 7.1.
Below are key valuation metrics over time for MDT.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
MDT | 2023-01-30 | 3.6 | 2.1 | 25.4 | 21.3 |
MDT | 2023-01-27 | 3.6 | 2.1 | 25.4 | 21.3 |
MDT | 2023-01-26 | 3.5 | 2.1 | 25.2 | 21.2 |
MDT | 2023-01-25 | 3.5 | 2.1 | 25.0 | 21.0 |
MDT | 2023-01-24 | 3.5 | 2.1 | 24.9 | 21.0 |
MDT | 2023-01-23 | 3.6 | 2.1 | 25.4 | 21.3 |
MDT Growth Metrics
- The 2 year price growth rate now stands at -5.58%.
- The 3 year price growth rate now stands at -10.78%.
- Its 2 year net cashflow from operations growth rate is now at 1.55%.

The table below shows MDT's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-09-30 | 30,808 | 6,290 | 4,321 |
2022-06-30 | 31,070 | 7,137 | 5,205 |
2022-03-31 | 31,686 | 7,346 | 5,039 |
2021-12-31 | 31,785 | 7,034 | 4,914 |
2021-09-30 | 31,797 | 7,162 | 4,704 |
2021-06-30 | 31,597 | 7,254 | 3,882 |
MDT's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- MDT has a Quality Grade of C, ranking ahead of 63.82% of graded US stocks.
- MDT's asset turnover comes in at 0.334 -- ranking 125th of 186 Medical Equipment stocks.
- XRAY, BAX, and PEN are the stocks whose asset turnover ratios are most correlated with MDT.
The table below shows MDT's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-07-30 | 0.334 | 0.665 | 0.104 |
2021-04-30 | 0.317 | 0.652 | 0.102 |
2021-01-29 | 0.296 | 0.639 | 0.076 |
2020-10-30 | 0.299 | 0.646 | 0.086 |
2020-07-31 | 0.303 | 0.658 | 0.097 |
2020-04-24 | 0.316 | 0.674 | 0.116 |
MDT Price Target
For more insight on analysts targets of MDT, see our MDT price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $145.56 | Average Broker Recommendation | 1.47 (Moderate Buy) |
MDT Stock Price Chart Interactive Chart >
MDT Price/Volume Stats
Current price | $86.58 | 52-week high | $114.31 |
Prev. close | $85.24 | 52-week low | $75.76 |
Day low | $85.10 | Volume | 5,129,644 |
Day high | $86.93 | Avg. volume | 6,795,852 |
50-day MA | $79.82 | Dividend yield | 3.19% |
200-day MA | $88.14 | Market Cap | 115.17B |
Medtronic PLC (MDT) Company Bio
Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US. In 2015, Medtronic acquired Irish–tax registered Covidien (a U.S. tax inversion to Ireland from 2007), in the largest U.S. corporate tax inversion in history, which enabled Medtronic to move its legal registration from the U.S. to Ireland. Medtronic operates in 140 countries and employs over 104,950 people. (Source:Wikipedia)
Latest MDT News From Around the Web
Below are the latest news stories about MEDTRONIC PLC that investors may wish to consider to help them evaluate MDT as an investment opportunity.
Medtronic plc (NYSE: MDT) Has Succeeded In Generating Interest In 2023, The Stock Is Up 12.07% Year-To-DateMedtronic plc (NYSE:MDT)’s traded shares stood at 4.95 million during the last session, with the company’s beta value hitting 0.73. At the close of trading, the stock’s price was $87.10, to imply a decrease of -0.55% or -$0.48 in intraday trading. The MDT share’s 52-week high remains $114.31, putting it -31.24% down since that peak … Medtronic plc (NYSE: MDT) Has Succeeded In Generating Interest In 2023, The Stock Is Up 12.07% Year-To-Date Read More » |
2 Beaten-Down Stocks With Stable Dividends to Buy In 2023Here is one thing that separates the best dividend stocks from the rest. Two excellent examples are Abbott Laboratories (NYSE: ABT) and Medtronic (NYSE: MDT). Both are solid dividend stocks with strong, long-term outlooks. |
Buying The Medtronic Turnaround StoryMedtronic (MDT) is a developer and manufacturer of medical devices for cardiac, neuroscience, surgery, and diabetes. MDT has revenue exposure diversified across countries and has maintained its R&D budgets equal to or higher than its revenue growth. In other words, MDT prioritizes product innovation that spurs revenue growth, rather than pushing products into its selling channels. MDT's R&D to revenue spend is also almost consistently higher than its two largest industry peers, which has enabled its category leadership across a variety of medical products. |
Medtronic (MDT) Stock Moves -0.55%: What You Should KnowMedtronic (MDT) closed at $87.10 in the latest trading session, marking a -0.55% move from the prior day. |
3 Ways To Shape Equitable OutcomesAs the global leader in healthcare technology, Medtronic sees inclusion, diversity, and equity (ID&E) as key to the innovation it needs to deliver life-transforming products and therapies for more people around the globe. |
MDT Price Returns
1-mo | 7.07% |
3-mo | 10.17% |
6-mo | -6.37% |
1-year | -12.49% |
3-year | -21.53% |
5-year | 24.32% |
YTD | 11.40% |
2022 | -22.55% |
2021 | -9.79% |
2020 | 5.70% |
2019 | 27.34% |
2018 | 15.18% |
MDT Dividends
Ex-Dividend Date | Type | Payout Amount | Change | ||||||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
Continue Researching MDT
Want to do more research on Medtronic plc's stock and its price? Try the links below:Medtronic plc (MDT) Stock Price | Nasdaq
Medtronic plc (MDT) Stock Quote, History and News - Yahoo Finance
Medtronic plc (MDT) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...